Pharmacokinetics and Exposure-Response During Infliximab Induction Therapy in Pediatric IBD Using Point-of-Care Assay.

J Clin Med · 2025 · PMC12653867 · PMID 41303004

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Tertile analysis of infliximab exposure showed an exposure–response relationship in which higher infliximab ELISA concentrations during induction therapy were associated with clinical remission at week 14 and biochemical response at week 14, but the trend did not reach statistical significance due to the small sample size.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.